Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Upsher-Smith Expands KYMBEE™ (Deflazacort) Family of Products with Launch of Oral Suspension for the Treatment of Duchenne Muscular Dystrophy

Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX) today announced the launch of KYMBEE™ (deflazacort) Oral Suspension, 22.75 mg/mL indicated for the treatment of Duchenne...

Strong Performance Across More Than 200 Customer Audits Highlighted by Piramal Pharma Solutions

and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer...

Cryo-EM Collaboration Between Gandeeva and Zymeworks Speeds Antibody Drug Discovery

therapeutics. These capabilities have been further leveraged through strategic partnerships with global biopharmaceutical companies. For more information please visit, www.zymeworks.com

Avenacy Announces the U.S. Launch of Bortezomib for Injection

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Bortezomib for Injection in the United States. The product contains the same active ingredient as VELCADE®, as approved by...

WISE Closes Oversubscribed €30 Million Series D Financing Round with ENEA Tech and Biomedical Joining as Strategic Investor

leaders in Italian and European biotech: founder of Gentium, a Nasdaq-listed company acquired in 2014 by Jazz Pharmaceuticals in a transaction worth approximately USD 1 billion, she is today President and co-founder of Bio4Dreams and holds...

Rugiet Launched Physician-Prescribed Peptide and Longevity Therapies, Setting a New Standard in Performance Medicine

is dispensed by a 503A compounding pharmacy, is third-party tested for purity and potency, and is sourced to pharmaceutical-grade standards that Rugiet was founded upon. Patients will receive a personalized protocol built around their specific...

EVERY and Huvepharma Announce Fourfold Expansion of Production Capacity

fermentation, announced a significant manufacturing expansion with its strategic partner, Huvepharma, a global pharmaceutical company with a focus on developing, manufacturing, and marketing human and animal health products. The agreement...

Results from Incyte’s Phase 3 frontMIND Trial of Tafasitamab Combination Show Prolonged Progression-Free Survival Presented at EHA 2026

stop treatment with MONJUVI if you have severe side effects. About Incyte® Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established...

SEREMI de Salud Grants Registration to Chile's First Finished Product Featuring Setria® Glutathione

legacy of fermentation excellence, Kyowa delivers premium, science-backed branded ingredients to the nutraceutical, pharmaceutical, functional food, beverage, and wellness industries. The portfolio features branded solutions like Cognizin®...

Roquette Highlights Scalable Innovations in Drug Delivery

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, will showcase its comprehensive portfolio of innovative drug delivery solutions Under the theme “One Roquette for Innovations,” Roquette’s Health & Pharma...

Exilby®, a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain, Receives Its First European Marketing Authorization from VERTANICAL; Pivotal U.S. Phase 3 Trial Underway

comprehensively characterized using chromatographic and spectrometric methods to quantify key constituents and ensure pharmaceutical-grade quality and product consistency. This level of standardization is critical, as cannabis-derived products...

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

Alpha Cognition Inc. a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, announced the top-line results from its BEACON real-world study evaluating provider-reported cognitive, behavioral,...

TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

TrueMed, the leader in AI-based pharmaceutical counterfeit detection, today announced a commercial partnership with one of the world's ten largest pharmaceutical companies. The agreement brings TrueMed's AI-powered authentication platform to three...

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

Niagen for their pre-clinical and clinical research on NAD+ biology. The program provides oral food-grade and pharmaceutical-grade Niagen research materials, scientific collaboration, and technical support. There are 45+ peer-reviewed published...

XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

medicines. About Shionogi Inc. Shionogi Inc. is a U.S. subsidiary of Shionogi & Co., Ltd., a global research‑driven pharmaceutical company committed to bringing to market the best possible medicines to aid the health and well-being of the patients...

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

in the science of nutrition, and IdB Holding S.p.A. (IdB), a global leader in the production of high potent active pharmaceutical ingredients for the pharmaceutical and the health food industries, announced that they have entered into a licensing...

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

SK bioscience announced that it has signed an agreement with Colombia's state-owned pharmaceutical company VECOL for vaccine technology transfer and local manufacturing cooperation as part of Colombia's national vaccine localization initiative....

Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

LIB Therapeutics Inc. (LIB), a privately-held, biopharmaceutical company with a recently approved novel, monthly, small-dose, third-generation PCSK9 inhibitor, LEROCHOL® (lerodalcibep-liga), announced results from two oral and two poster...

Digi-Tech Pharma & AI Conference 2026

The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

per month. Today, eptinezumab is launched in more than 30 markets worldwide. About H. Lundbeck A/S Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed...